Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JS

Juergen Scheele — 7 Patents

AMAmgen: 7 patents #495 of 2,867Top 20%
Munich, DE: #1,522 of 11,432 inventorsTop 15%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Juergen Scheele has been granted 7 US patents while listed as an inventor at Amgen. The first was granted in 2015 and the most recent in April 2023. Juergen Scheele ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Juergen Scheele in Munich, DE.

Patents per Year

Patents granted per year, 2015 to 2023Bar chart with a peak of 1 patents in 2015.peak 12015: 1 patents20152016: 1 patents20162017: 1 patents20172018: 1 patents20182020: 1 patents20202021: 1 patents20212023: 1 patents2023

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
11633408 Prevention of adverse effects caused by CD3 specific binding domains Gerhard Zugmaier, Dirk Nagorsen 2023-04-25
11084876 Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains Peter Kufer, Dirk Nagorsen, Gerhard Zugmaier, Matthias Klinger, Patrick Hoffmann +2 more 2021-08-10
10696744 Means and methods for treating DLBCL Gerhard Zugmaier, Dirk Nagorsen 2020-06-30
10130638 Prevention of adverse effects caused by CD3 specific binding domains Gerhard Zugmaier, Dirk Nagorsen 2018-11-20
9688760 Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains Peter Kufer, Dirk Nagorsen, Gerhard Zugmaier, Matthias Klinger, Patrick Hoffmann +2 more 2017-06-27
9486475 PPS for the prevention of potential adverse effects caused by CD3 specific binding domains Peter Kufer, Dirk Nagorsen, Gerhard Zugmaier, Matthias Klinger, Patrick Hoffmann +2 more 2016-11-08
9192665 Means and methods for treating DLBCL Gerhard Zugmaier, Dirk Nagorsen 2015-11-24